Jounce Therapeutics
JNCE
#9239
Rank
ยฃ75.46 M
Marketcap
ยฃ1.40
Share price
0.00%
Change (1 day)
-48.34%
Change (1 year)

Revenue for Jounce Therapeutics (JNCE)

Revenue in 2022 (TTM): ยฃ67.77 Million

According to Jounce Therapeutics 's latest financial reports the company's current revenue (TTM ) is ยฃ60.91 Million. In 2021 the company made a revenue of ยฃ19.93 Million a decrease over the revenue in the year 2020 that were of ยฃ45.73 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Jounce Therapeutics from 2016 to 2022

Annual revenue

Year Revenue Change
2022 (TTM) ยฃ67.77 M240.03%
2021 ยฃ19.93 M-56.41%
2020 ยฃ45.73 M-59.44%
2019 ยฃ0.11 B119.54%
2018 ยฃ51.36 M-3.1%
2017 ยฃ53.01 M75.85%
2016 ยฃ30.14 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA